Trial document

drksid header


Trial Description

start of 1:1-Block title


Evidence-Based, Stepped Care in Late Adolescents and Young Adults with ADHS

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym


end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Regarding the treatment of adult ADHD many different methods have been proven to be useful. In German national practise the daily treatment of the patients is not only influenced by the results of clinical studies but also by recommendations of treatment guidelines and by requirements of sublegal institutions (gemeinsamer Bundesausschuss). The main aspect of these regulations is the requirement of a stepped care approach as the most useful treatment in ADHD patients.
The stepped care model has not been validated yet.
Thus this study will analyze the effect of a stepped care treatment in a trial.
The study is designed in a 2 step design. In the first step the patients will be randomized in one of three arms.
In step 2 they will be randomized and treated according response.

With amendment from December 20th 2016 the inclusion criteria "age" changed (from old = 16-35 years to new = 16-45 years). The amendment was accepted from the Ethic Ethic committee on January 25th 2017.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Due to specific in- and exclusion criteria of pharmacological studies it is hard to generalize the results of the pharmacological trials and to assign the results to the general population. Regarding low level psychosocial treatment options psychoeducation is well established in daily practice (D‘Amelio et al. 2009). TASH interventions were found useful in children and adolescents (McGrath et al. 2011). TASH in children and adolescents is directed to the parents of the ADHD patient. In adult psychiatry the ADHD patient is the recipient of the treatment. Insofar the results of studies in children and adolescent cannot be transferred directly to adulthood. In adults to date there is only one published randomised controlled pilot study evaluating an 8-week bibliotherapy program with minimal therapists contact by phone calls (Stevenson et al., 2003) which revealed significant improvement of the symptoms of ADHD.

The few available studies and the complete lack of evidence from adults underline the need for the current study to clarify these in a stepped care design.

Thus this study is designed as follows:

Step 1 : Randomization into either:

- Face-to-face psychoeducation
- Telefon assisted self help programm (TASH)
- waiting control group followed by TASH

Step 2 (depending on response):

- single counseling and symptom control
or (randomized)
- neurofeedback with single counseling
- single counseling
or (randomized)
- Methylphenidat (according SMPC) and Neurofeedback
- Methylphenidat (according SMPC)

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00008975
  •   2015/10/23
  •   [---]*
  •   yes
  •   Approved
  •   161/15, Ethik-Kommission bei der Ärztekammer des Saarlandes
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   F90 -  Hyperkinetic disorders
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Step 1: Face-to-face Psychoeducation (PE) for three months. PE includes 8 sessions.
  •   Step 1: Telefon assisted self help programm (TASH) for three months; TASH includes 8 sessions. The sessions could be conducted by:
    physicians, psychiatrists, psychotherapists and psychotherapists in education
  •   Step 1: Waiting Control Group for three months followed by TASH
  •   Step 2 a: If response of IDA-R is ≤ 18 the patients get six counseling sessions for symptom control for a duration of three months. The patients do not get medication or psychotherapeutic treatment.
  •   Step 2 ba: If response of IDA-R > 19 ≤ 27
    patients will be randomized and get six sessions of counseling and 30 sessions of neurofeedback for three months.
  •   Step 2 bb: If response of IDA-R > 19 ≤ 27 the patients will be randomized and get six single counseling sessions for three months.
  •   Step 2 ca: If IDA-R≥28 the Patients wil be randomized and get a combined neurofeedback and methylphenidat treatment (medication will be prescribed according SMPC) for three months. In total 30 neurofeedback session (with 2-3 sessions per week) are planned.
  •   Step 2 ca: If IDA-R≥28 the Patients wil be randomized and get a methylphenidat treatment (medication will be prescribed according SMPC) for three months.
end of 1:N-Block interventions
start of 1:1-Block design


  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Blinded
  •   assessor
  •   Active control (effective treament of control group), Control group receives no treatment
  •   Treatment
  •   Other
  •   N/A
  •   No
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Change of the ADHD symptoms by blinded expert rater via structured interview IDA-R at T0//1, T2, T3 and T4

T0/T1: at start of study
T2: after completion of step 1 (after 3 months)
T3: after completion of step 2 (after 6 months)
T4: after 3 months follow-up (after 9 months)

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

- WFIRS-S, which is a self-rating scale for the assessment of functional
problems in 7 domains of daily life; at T1; T2, T3, T4.
- Wender-Reimherr Interview. This is the
German version of a structured interview to assess ADHD symptoms; at T1, T2, T3 and T4
- The AAQOL is a 29-item disease-specific quality-of-life measure; at T1, T2, T3 and T4
- SCL-90-R : a 90-item self-report
symptom inventory to measure psychological symptoms and psychological distress: at T1, T2, T3 and T4
- PSQI : self-rated questionnaire which assesses sleep quality and disturbance over a 1-month time interval; at T1, T2, T3 and T4
- Anger-management will be assessed by the State-Trait Anger Expression Inventory – 2 (STAXI-2); at T1, T2, T3 and T4
- For the assessment of the psychopathology of comorbid conditions the Symptom-Checklist--90-symptom will be used; at T0, T1, T2, T3 and T4
- Aspects of quality of life will be assessed by the Adult ADHD Quality-of-Life Scale Questionnaire (AAQOL-29) at T1, T2, T3 and T4.
- M.I.N.I. 6.0: The M.I.N.I is a short, structured diagnostic interview and is a
structured psychiatric interview of choice for psychiatric evaluation and outcome tracking in
clinical psychopharmacology trials and epidemiological studies; at T0.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • other 
  • University Medical Center 
  • University Medical Center 
  • other 
  • University Medical Center 
  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment


  •   Actual
  •   2016/01/28
  •   279
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   16   Years
  •   45   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

ADHD according to the DSM-5 criteria as measured by the IDA-R interview, age between 16;00 to 45;11 years;

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

IQ ≤ 80, acute substance dependence (alcohol and illegal
drugs), antisocial personality disorder, any psychotic disorder, any severe affective or bipolar disorder, epilepsy, any significant heart disease, pregnancy, insufficient command over the German language

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses


end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Bundesministerium für Bildung und Forschung (BMBF) Dienstsitz Berlin
    • Friedrichstraße 130 B
    • 10117  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state


  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.